Maintaining the highest quality standards is paramount in the pharmaceutical industry, where any deviation from protocol can have serious health consequences. Pharmaceutical nonconformances encompass a range of issues, including deviations from procedures, incidents that occur during manufacturing or distribution, and market complaints received after a product reaches consumers. Identifying and addressing these nonconformances promptly is crucial for ensuring product safety, efficacy, and regulatory compliance. By analysing these issues, pharmaceutical companies can continuously improve their processes, minimize risks, and ultimately deliver medications patients can trust.
What are Deviations?
A deviation is any departure from approved processes, procedures, instructions, specifications, or established standards. In the pharmaceutical industry, deviations can occur during drug product development, manufacturing, labelling, packing, sampling, testing, storage, distribution, and other processes.
The definition of deviation may vary depending on the regulatory authority and requirements governing the company’s processes.
What is Deviation Management?
Deviation management is the systematic process of identifying, assessing, and addressing any deviations that occur against approved instructions or established standards within a company. The objective of deviation management in the pharmaceutical industry is to promptly identify, investigate, and resolve any deviations. Deviation management is an essential QMS process in a Pharmaceutical Quality Management System.
By promptly identifying and addressing deviations, pharmaceutical companies can provide safe, uniform, high quality, and effective products to patients while maintaining their reputation in the market and compliance with regulatory requirements. Effective deviation management plays a crucial role in handling diverse types of deviations, streamlining processes, and fostering continuous improvement.
What Are the Different Types of Deviation?
Unplanned Deviations:
Unplanned deviations refer to a departure from approved procedures without prior notice or intention. Various factors, such as equipment malfunction, error during execution, environmental events, or others, can cause them. Unplanned deviations can sometimes significantly impact product quality and safety, and such deviations should be investigated promptly to identify the true root cause and prevent them from happening again.
Refer to below examples:
- The sudden breakdown of manufacturing equipment leads to deviations from standard operating conditions and affects product quality.
- Process parameters observed out of specified limit.
(E.g. Mixing of API performed at 25 rpm, instead of 20 rpm).
- Temperature during dispensing was observed out of limit.
(E.g. During dispensing of raw material temperature was observed out of limit. Temperature range specified in BMR 20-30°C, and observed temperature is 32°C).
- Deviations can also be caused by unforeseen events like power outages, extreme weather conditions, or natural disasters that disrupt manufacturing.
(E.g. Power failure was observed and batch processing was stopped)
- Accidental introduction of foreign materials into the production process, leading to material contamination and deviation from product specifications.
When an unplanned deviation occurs, root cause analysis investigations are performed to identify the root cause or most probable causes for the deviation. Based on the identified root cause or most probable cause, corrective and preventive actions are identified. The investigation team shall identify the actions required to correct the non-conformance and actions required for prevent the recurrence of the non-conformance. Such set of actions are called as corrective and preventive actions.
The process of CAPA implementation varies based on every company’s established procedures. Companies assess the severity and categorization of the deviation based on risk to determine whether the CAPA process is required to be initiated.
Planned Deviations:
Planned deviations refer to pre-approved and intentional departure from standard procedures or processes. These deviations are planned and justified in advance, serving various purposes, such as process improvement, to save transit time and for study, feasibility purpose. Scope is limited for certain period of time or specific to certain batches. This is generally followed by organization knowingly when there is a priority to protect the product, quality, patient safety etc.
Refer to below examples:
- Use of alternative Equipment for certain batches / period during manufacturing to ensure product quality/safety is protected.
- Quarantine Release of Finished goods prior to complete a Microbial testing to save the trsnsit time and ensure continuity of supply to the market.
- Temporarily adopting an alternative testing method to validate its accuracy and reliability compared to the standard method.
Incidents:
Incidents in production or operation sites in the pharmaceutical industry can encompass a wide range of unexpected events, accidents, or issues that occur during the manufacturing or operational processes. These incidents can vary in severity and may impact product quality, employee safety, environmental compliance, and operational efficiency.
Refer to below examples:
- Spillage of raw material during dispensing, Manufacturing.
- Spillage of bulk product, intermediate, granules during Manufacturing.
- Damage of shipper during transferring of finished goods to the ware house
Some organizations handle Deviations and Incidents as separate processes, whereas some organizations handle them under the same procedure.
Market Complaints:
In the pharmaceutical industry, a market complaint refers to any feedback, concern, or complaint received from customers, healthcare professionals, or other stakeholders regarding a pharmaceutical product. These complaints can relate to various aspects of the product, including its efficacy, safety, quality, packaging, labelling, or usability.
Refer to below examples:
- Complaints from patients or healthcare professionals reporting adverse reactions or side effects associated with a pharmaceutical product. These complaints may indicate potential safety concerns that require investigation and regulatory reporting.
- Complaints about issues related to the quality of a pharmaceutical product, such as discoloration, unusual odour or taste, or physical defects in tablets or capsules.
- Complaints regarding errors or discrepancies in the packaging or labelling of a pharmaceutical product, such as incorrect dosage instructions, missing or incorrect labels, or packaging that is difficult to open or use.
Market complaints play a crucial role in quality assurance and regulatory compliance within the pharmaceutical industry. By effectively managing and addressing market complaints, pharmaceutical companies can uphold the safety, efficacy, and quality of their products, as well as maintain trust and confidence among stakeholders.
Key Takeaways for me?
In summary, non-conformances in the pharmaceutical industry are crucial for ensuring regulatory compliance, protecting patient safety, maintaining product quality, managing risks, driving continuous improvement, and enhancing customer satisfaction. Management of Deviations, Incidents and Market Complaints plays a vital role for industry to upload the regulatory expectations, product quality and patient safety. Effective non-conformance management is integral to addressing these multifaceted issues, helping companies uphold the highest standards of quality, safety, and compliance while demonstrating a commitment to customer trust and loyalty.
References:
- Title 21-Food and Drugs, Chapter I–Food and Drug Administration
- Part 211-Current Good Manufacturing Practice for Finished Pharmaceuticals
- Investigations for non-conformities guideline published by Indian Pharmaceutical Alliance.
- ISO 9001:2015 in Section 10.2
- ISO 13485:2016 in Section 8.3
- FDA 21 CFR Part 820 in Section 21 CFR 820.90
WP Digitals